Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Patients With Type 1 Diabetes Using Vibration-Controlled Transient Elastography and Noninvasive Scores

NCT04595474 is registered in ClinicalTrials.gov with Joslin Diabetes Center as lead sponsor.

NCT NCT04595474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04595474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Patients With Type 1 Diabetes Using Vibration-Controlled Transient Elastography and Noninvasive Scores
Lead sponsor
Joslin Diabetes Center
Phase
Observational
Overall status
Active, not recruiting
Start date
January 14, 2021
Completion date
December 30, 2026
Enrollment
533 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver, fibrosis, liver, nonalcoholic fatty liver, nonalcoholic steatohepatitis, type 1 diabetes